Alma Osmanovic

2.1k total citations
35 papers, 454 citations indexed

About

Alma Osmanovic is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Alma Osmanovic has authored 35 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 16 papers in Molecular Biology and 11 papers in Neurology. Recurrent topics in Alma Osmanovic's work include Neurogenetic and Muscular Disorders Research (22 papers), RNA modifications and cancer (9 papers) and Amyotrophic Lateral Sclerosis Research (9 papers). Alma Osmanovic is often cited by papers focused on Neurogenetic and Muscular Disorders Research (22 papers), RNA modifications and cancer (9 papers) and Amyotrophic Lateral Sclerosis Research (9 papers). Alma Osmanovic collaborates with scholars based in Germany, Bosnia and Herzegovina and Sweden. Alma Osmanovic's co-authors include Susanne Petri, Olivia Schreiber‐Katz, Lars Hendrik Müschen, Claudia D. Wurster, Albert C. Ludolph, Ruthild G. Weber, Matthias Preller, Peter Raab, Bernd Auber and René Günther and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Alma Osmanovic

32 papers receiving 447 citations

Peers

Countries citing papers authored by Alma Osmanovic

Since Specialization

Citations

This map shows the geographic impact of Alma Osmanovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alma Osmanovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alma Osmanovic more than expected).

Fields of papers citing papers by Alma Osmanovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alma Osmanovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alma Osmanovic. The network helps show where Alma Osmanovic may publish in the future.

Co-authorship network of co-authors of Alma Osmanovic

This figure shows the co-authorship network connecting the top 25 collaborators of Alma Osmanovic. A scholar is included among the top collaborators of Alma Osmanovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alma Osmanovic. Alma Osmanovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Compound Muscle Action Potential (CMAP) Amplitude Trajectories and Pattern in Adults with 5q‐Spinal Muscular Atrophy Receiving Nusinersen Therapy: A Multicenter, Binational Observational Study 2025 ·European Journal of Neurology ·Bogdan Bjelica, (unknown), Alma Osmanovic, Olivia Schreiber‐Katz, (unknown), Katja Kollewe, (unknown), Maren Freigang, Isabell Cordts, (unknown), C Vogt, (unknown), René Günther, Marcus Deschauer, Jan Christoph Koch, Matthias Türk, Martin Regensburger, Christoph Neuwirth, Susanne Petri	0
2	Risdiplam therapy in adults with 5q-SMA: observational study on motor function and treatment satisfaction 2024 ·BMC Neurology ·Bogdan Bjelica, (unknown), (unknown), Alma Osmanovic, Olivia Schreiber‐Katz, Susanne Petri	4
3	An observational cohort study on pulmonary function in adult patients with 5q-spinal muscular atrophy under nusinersen therapy 2023 ·Journal of Neurology ·Bogdan Bjelica, (unknown), Alma Osmanovic, Olivia Schreiber‐Katz, Susanne Petri	9
4	Cranial nerve involvement in patients with immune-mediated neuropathy: An observational blink reflex study 2023 ·Clinical Neurophysiology ·Sonja Körner, (unknown), Lars Hendrik Müschen, Tabea Seeliger, Olivia Schreiber‐Katz, Stefan Gingele, Martin Stangel, Reinhard Dengler, Susanne Petri, Thomas Skripuletz, Alma Osmanovic	0
5	Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers—A Prospective, Cross-Sectional, Multi-Center Analysis 2023 ·Brain Sciences ·(unknown), (unknown), (unknown), Claudia D. Wurster, Isabell Cordts, Benjamin Stolte, Daniel Zeller, Željko Uzelac, (unknown), Tim Hagenacker, Marcus Deschauer, Paul Lingor, Albert C. Ludolph, Dorothée Lulé, Susanne Petri, Alma Osmanovic, Olivia Schreiber‐Katz	11
6	Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy 2022 ·Human Gene Therapy ·Benjamin Stolte, Olivia Schreiber‐Katz, René Günther, Claudia D. Wurster, Susanne Petri, Alma Osmanovic, Maren Freigang, Željko Uzelac, Markus Leo, Otgonzul von Velsen, Wibke Bayer, Ulf Dittmer, Christoph Kleinschnitz, Tim Hagenacker	11
7	A SUMO4 initiator codon variant in amyotrophic lateral sclerosis reduces SUMO4 expression and alters stress granule dynamics 2022 ·Journal of Neurology ·Alma Osmanovic, (unknown), (unknown), (unknown), Anibh M. Das, (unknown), Frank Brand, Susanne Petri, Ruthild G. Weber	5
8	Cerebrospinal Fluid Parameters in Antisense Oligonucleotide-Treated Adult 5q-Spinal Muscular Atrophy Patients 2021 ·Brain Sciences ·Lars Hendrik Müschen, Alma Osmanovic, (unknown), Konstantin Fritz Jendretzky, (unknown), Paul Bronzlik, (unknown), (unknown), Nora Möhn, Martin W. Hümmert, Stefan Gingele, Friedrich Götz, Martin Stangel, Thomas Skripuletz, Olivia Schreiber‐Katz, Susanne Petri	16
9	Heterozygous DHTKD1 Variants in Two European Cohorts of Amyotrophic Lateral Sclerosis Patients 2021 ·Genes ·Alma Osmanovic, (unknown), Helge Martens, (unknown), Kathrin Müller, Olivia Schreiber‐Katz, Friedrich Feuerhake, Claus‐Dieter Langhans, Gunnar Schmidt, Peter M. Andersen, Albert C. Ludolph, Jochen H. Weishaupt, Frank Brand, Susanne Petri, Ruthild G. Weber	7
10	An unusual presentation of Huntington’s disease 2021 ·SHILAP Revista de lepidopterología ·(unknown), Alma Osmanovic, (unknown), (unknown), (unknown), Corinna Hendrich, Georg Berding, Johanna Seifert, Stefan Bleich, (unknown), Tillmann H. C. Krüger, Adrian Groh	3
11	Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy 2021 ·Orphanet Journal of Rare Diseases ·Maren Freigang, Petra Steinacker, Claudia D. Wurster, Olivia Schreiber‐Katz, Alma Osmanovic, Susanne Petri, Jan Christoph Koch, Kevin Rostásy, Björn Falkenburger, Albert C. Ludolph, Markus Otto, Andreas Hermann, René Günther	14
12	Identification of a rare SEPT9 variant in a family with autosomal dominant Charcot-Marie-Tooth disease 2020 ·BMC Medical Genetics ·Gerrit M. Große, Christine Bauer, Bruno Kopp, Christoph Schrader, Alma Osmanovic	8
13	Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group 2020 ·Journal of Neurology ·(unknown), Magdalena Kuźma‐Kozakiewicz, Maria Piotrkiewicz, Marta Gromicho, Julian Großkreutz, Peter M. Andersen, Mamede de Carvalho, Hilmi Uysal, Alma Osmanovic, Olivia Schreiber‐Katz, Susanne Petri, Sonja Körner	25
14	SPG7 mutations in amyotrophic lateral sclerosis: a genetic link to hereditary spastic paraplegia 2020 ·Journal of Neurology ·Alma Osmanovic, (unknown), (unknown), (unknown), Mike P. Wattjes, (unknown), (unknown), Bernd Auber, Peter Raab, (unknown), Matthias Preller, Susanne Petri, Ruthild G. Weber	18
15	Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy 2020 ·Journal of Neurology ·Alma Osmanovic, (unknown), (unknown), Lars Hendrik Müschen, (unknown), (unknown), Lejla Paracka, Sonja Körner, Katja Kollewe, Susanne Petri, Olivia Schreiber‐Katz	32
16	Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany 2020 ·Orphanet Journal of Rare Diseases ·(unknown), Alma Osmanovic, Lars Hendrik Müschen, Susanne Petri, Olivia Schreiber‐Katz	21
17	Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1 ^G93A mouse model of amyotrophic lateral sclerosis 2019 ·Journal of Tissue Engineering and Regenerative Medicine ·(unknown), Klaus Jan Rath, (unknown), (unknown), (unknown), Alma Osmanovic, (unknown), Stephan Klöß, Ulrike Köhl, Susanne Petri	10
18	Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen 2019 ·Journal of Neurology ·(unknown), Claudia D. Wurster, Petra Steinacker, René Günther, Jan Christoph Koch, Paul Lingor, Željko Uzelac, Simon Witzel, Kurt H. Wollinsky, Benedikt Winter, Alma Osmanovic, Olivia Schreiber‐Katz, (unknown), Albert C. Ludolph, Susanne Petri, Andreas Hermann, Markus Otto	51
19	Routine Cerebrospinal Fluid Cytology Reveals Unique Inclusions in Macrophages During Treatment With Nusinersen 2019 ·Frontiers in Neurology ·Stefan Gingele, Martin W. Hümmert, Sascha Alvermann, Konstantin Fritz Jendretzky, Lena Bönig, (unknown), Philipp Schwenkenbecher, Kurt‐Wolfram Sühs, Lars Hendrik Müschen, Alma Osmanovic, Olivia Schreiber‐Katz, Martin Stangel, Susanne Petri, Thomas Skripuletz	16
20	Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See? 2016 ·International Journal of Molecular Sciences ·Refik Pul, Alma Osmanovic, (unknown), Amelie Pielen, Kaweh Pars, Philipp Schwenkenbecher, (unknown), Özlem Kayım Yıldız, Benedikt Frank, Martin Stangel, Thomas Skripuletz	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact